Otofarma SpA (MIL:OTO) Long-Term Debt: €1.31 Mil (As of Dec. 2024)


MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.80
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Long-Term Debt?

Otofarma SpA MIL:OTO 16 Long-Term Debt is €1.31 Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Otofarma SpA's Long-Term Debt for the quarter that ended in Dec. 2024 was €1.31 Mil.

Otofarma SpA's quarterly Long-Term Debt increased from . 20 (€0.00 Mil) to Dec. 2023 (€0.97 Mil) and increased from Dec. 2023 (€0.97 Mil) to Dec. 2024 (€1.31 Mil).

Otofarma SpA's annual Long-Term Debt increased from . 20 (€0.00 Mil) to Dec. 2023 (€0.97 Mil) and increased from Dec. 2023 (€0.97 Mil) to Dec. 2024 (€1.31 Mil).

Otofarma SpA  (MIL:OTO) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Otofarma SpA Long-Term Debt Related Terms

Otofarma SpA Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Long-Term Debt Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Long-Term Debt
0.97 1.31

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Long-Term Debt 0.97 1.31
MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €1.31 Mil mean?
Otofarma SpA (MIL:OTO) has a Long-Term Debt of €1.31 Mil as of Dec. 2024.
Is Otofarma SpA's Long-Term Debt too high?
Otofarma SpA's current Long-Term Debt is €1.31 Mil. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Long-Term Debt compare to ABT and SYK?
Otofarma SpA's Long-Term Debt of €1.31 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Otofarma SpA's current Long-Term Debt is €1.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Long-Term Debt of €1.31 Mil. The current Long-Term Debt is €1.31 Mil. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Long-Term Debt is €1.31 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.80
Price